Streamlining biologics development leveraging small scale studies for greater efficiency
Biopharmaceutical manufacturers face increasing pressure to deliver safe, effective therapies with greater efficiency. Small-scale downstream process studies have become a powerful approach to optimize biologics manufacturing—enabling smoother technology transfer, more robust process validation, and comprehensive regulatory support. By accurately simulating full-scale conditions in a controlled lab environment, these studies help to identify risks, refine control strategies, and generate critical data while saving time and resources.
In this webinar, our experts will demonstrate how a data-driven approach to small-scale studies accelerates timelines, strengthen decision-making, and address full-scale challenges across diverse biologics modalities. Through our case studies, you will see how these methods drive higher product quality and more efficient regulatory approvals.
Key learning objectives:
- Discover how small-scale downstream process studies enable seamless tech transfer from development to manufacturing
- Understand the critical role of small-scale studies in process validation and in meeting evolving regulatory expectations for biologics manufacturing
- Learn how to apply small-scale study data to optimize processes, enhance product quality, and accelerate time to market
Biopharmaceutical manufacturers face increasing pressure to deliver safe, effective therapies with greater efficiency. Small-scale downstream process studies have become a powerful approach to optimize biologics manufacturing—enabling smoother technology transfer, more robust process validation, and comprehensive regulatory support. By accurately simulating full-scale conditions in a controlled lab environment, these studies help to identify risks, refine control strategies, and generate critical data while saving time and resources.
In this webinar, our experts will demonstrate how a data-driven approach to small-scale studies accelerates timelines, strengthen decision-making, and address full-scale challenges across diverse biologics modalities. Through our case studies, you will see how these methods drive higher product quality and more efficient regulatory approvals.
Key learning objectives:
- Discover how small-scale downstream process studies enable seamless tech transfer from development to manufacturing
- Understand the critical role of small-scale studies in process validation and in meeting evolving regulatory expectations for biologics manufacturing
- Learn how to apply small-scale study data to optimize processes, enhance product quality, and accelerate time to market
Related Content